Mechanisms of polyclonal hypogammaglobulinaemia in multiple myeloma (MM) Maria-Christina KyrtsonisAthanasia MouzakiAlice Maniatis Review 01 July 1999 Pages: 73 - 77
Cancer gene and immunotherapy: recent developments Peter JantscheffRichard HerrmannChristoph Rochlitz Review 01 July 1999 Pages: 78 - 85
Interleukin-10: a cytokine used by tumors to escape immunosurveillance Flavio Salazar-Onfray Review 01 July 1999 Pages: 86 - 94
Locally advanced breast cancer in Saudi Arabia: high frequency of stage III in a young population Adnan A EzzatEzzeldin M IbrahimRobert K Stuart Original Paper 01 July 1999 Pages: 95 - 103
Phase II trial of high-dose dexamethasone for untreated patients with primary systemic amyloidosis Morie A GertzMartha Q LacyRobert A Kyle Original Paper 01 July 1999 Pages: 104 - 109
Transforming growth factor-β and multidrug resistance in chronic lymphocytic leukemia William R FriedenbergSherry A SalzmanJames K Burmester Original Paper 01 July 1999 Pages: 110 - 118
Assessment ofall-trans retinoic acid (ATRA) efficacy as a single agent in primary lymphoid neoplasia Nalini SwaminathanGabriel Lopez-BeresteinStuart Rudikoff Original Paper 01 July 1999 Pages: 119 - 128
Paraneoplastic syndromes in 68 cases of resectable non-small cell lung carcinoma: can they help in early detection? N CampanellaA MoracaM Al-Refai Original Paper 01 July 1999 Pages: 129 - 133
Concurrent occurrence of three neoplasms including non-Hodgkin’s lymphoma, renal cell carcinoma and leiomyoma in the same kidney Dilek DinçolAli AricanAbdülkadir Cengiz Case Report 01 July 1999 Pages: 134 - 138
Hepatosplenic candidiasis after neutropenic phase of acute leukaemia M ČolovićV LazarevićJ Bila Case Report 01 July 1999 Pages: 139 - 142